Methotrexate: the gold standard without standardisation

dc.contributor.author	Kay, Jonathan
dc.contributor.author	Westhovens, Rene
dc.date	2022-08-11T08:10:51.000
dc.date.accessioned	2022-08-23T17:22:18Z
dc.date.available	2022-08-23T17:22:18Z
dc.date.issued	2009-07-01
dc.date.submitted	2015-04-17
dc.identifier.citation	Ann Rheum Dis. 2009 Jul;68(7):1081-2. doi: 10.1136/ard.2008.102822. <a href="http://dx.doi.org/10.1136/ard.2008.102822">Link to article on publisher's site</a>
dc.identifier.issn	0003-4967 (Linking)
dc.identifier.doi	10.1136/ard.2008.102822
dc.identifier.pmid	19525405
dc.identifier.uri	http://hdl.handle.net/20.500.14038/48717
dc.language.iso	en_US
dc.relation	<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=19525405&dopt=Abstract">Link to Article in PubMed</a>
dc.relation.url	http://dx.doi.org/10.1136/ard.2008.102822
dc.subject	Antirheumatic Agents
dc.subject	Arthritis, Rheumatoid
dc.subject	Humans
dc.subject	Methotrexate
dc.subject	Musculoskeletal Diseases
dc.subject	Rheumatology
dc.subject	Skin and Connective Tissue Diseases
dc.title	Methotrexate: the gold standard without standardisation
dc.type	Journal Article
dc.source.journaltitle	Annals of the rheumatic diseases
dc.source.volume	68
dc.source.issue	7
dc.identifier.legacycoverpage	https://escholarship.umassmed.edu/rheumatology_pubs/115
dc.identifier.contextkey	7002942
dc.identifier.submissionpath	rheumatology_pubs/115
dc.contributor.department	Department of Medicine, Division of Rheumatology
dc.source.pages	1081-2